211 related articles for article (PubMed ID: 16264825)
1. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor family receptors and inhibitors: radiation response modulators.
Sartor CI
Semin Radiat Oncol; 2003 Jan; 13(1):22-30. PubMed ID: 12520461
[TBL] [Abstract][Full Text] [Related]
3. Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
Harari PM; Huang SM
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):976-83. PubMed ID: 14967459
[TBL] [Abstract][Full Text] [Related]
4. Antimetabolite radiosensitizers.
Shewach DS; Lawrence TS
J Clin Oncol; 2007 Sep; 25(26):4043-50. PubMed ID: 17827452
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
6. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.
Baumann M; Krause M; Dikomey E; Dittmann K; Dörr W; Kasten-Pisula U; Rodemann HP
Radiother Oncol; 2007 Jun; 83(3):238-48. PubMed ID: 17502118
[TBL] [Abstract][Full Text] [Related]
7. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.
Tabernero J
Mol Cancer Res; 2007 Mar; 5(3):203-20. PubMed ID: 17374728
[TBL] [Abstract][Full Text] [Related]
8. Antiepidermal growth factor receptor radiosensitizers in rectal cancer.
Glynne-Jones R; Mawdsley S; Harrison M
Anticancer Drugs; 2011 Apr; 22(4):330-40. PubMed ID: 21346551
[TBL] [Abstract][Full Text] [Related]
9. Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation.
Debucquoy A; Machiels JP; McBride WH; Haustermans K
Clin Cancer Res; 2010 May; 16(10):2709-14. PubMed ID: 20427690
[TBL] [Abstract][Full Text] [Related]
10. Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies.
Viloria-Petit AM; Kerbel RS
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):914-26. PubMed ID: 14967451
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME
Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.
Patel JD
Curr Opin Oncol; 2006 Nov; 18(6):609-14. PubMed ID: 16988582
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
Heymach JV; Nilsson M; Blumenschein G; Papadimitrakopoulou V; Herbst R
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4441s-4445s. PubMed ID: 16857825
[TBL] [Abstract][Full Text] [Related]
14. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy.
Bussink J; Kaanders JH; van der Kogel AJ
Radiother Oncol; 2007 Jan; 82(1):10-7. PubMed ID: 17141899
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Modjtahedi H; Essapen S
Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
[TBL] [Abstract][Full Text] [Related]
16. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer.
Hamakawa H; Nakashiro K; Sumida T; Shintani S; Myers JN; Takes RP; Rinaldo A; Ferlito A
Head Neck; 2008 Jun; 30(6):800-9. PubMed ID: 18429007
[TBL] [Abstract][Full Text] [Related]
17. Biology of interactions: antiepidermal growth factor receptor agents.
Harari PM; Allen GW; Bonner JA
J Clin Oncol; 2007 Sep; 25(26):4057-65. PubMed ID: 17827454
[TBL] [Abstract][Full Text] [Related]
18. Rational bases for the development of EGFR inhibitors for cancer treatment.
Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]